Lantern Pharma Inc Equity-NMS: LTRN

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :	$3.76
Open :	$3.71
Today's high :	$3.82
Today's low :	$3.65
52W low :	$3.65
52W high :	$6.2
1Y :	-20.24%
5Y :	-75.16%
Shares O/S :	10.87 M
Market cap :	39.67 M

What is the share price of Lantern Pharma Inc today?

Lantern Pharma Inc (LTRN) share price as of September 23, 2023, is $3.65. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Lantern Pharma Inc?

Yes, Indian Investors can invest in the Lantern Pharma Inc (LTRN) Share by opening an international trading account with Angel One.

How can I purchase Lantern Pharma Inc shares in India?

Purchasing Lantern Pharma Inc (LTRN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Lantern Pharma Inc (LTRN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Lantern Pharma Inc?

Yes, you can purchase fractional shares of Lantern Pharma Inc (LTRN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Lantern Pharma Inc?

The market capitalization of Lantern Pharma Inc on September 23, 2023, is $39.67 M.

In which sector Lantern Pharma Inc belongs?

Lantern Pharma Inc operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Lantern Pharma Inc stocks?

In order to invest in Lantern Pharma Inc (LTRN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Lantern Pharma Inc. is a clinical-stage biopharmaceutical company. The Company is focused on leveraging its RADR artificial intelligence (AI) and machine learning (ML) platform to discover biomarker signatures that identify patients most likely to respond to its pipeline of genomically targeted therapeutics. Its RADR AI includes more than 25 billion data points and uses big data analytics and ML to uncover biologically relevant genomic signatures correlated to drug response. Its portfolio consists of four compounds, which includes LP-100, LP-300, LP-184, and LP-284, and an Antibody Drug Conjugate (ADC) program: two drug candidates in clinical phases, two in the pre-IND preclinical stage and its ADC program in research optimization. All these drug candidates and its ADC program are leveraging precision oncology, AI, and genomic driven approaches. It has two drug candidates in clinical development, which are LP-100 and LP-300. It also has two new drug candidates, LP-184 and LP-284.